Evidence map›Paper›PMID 31802371›Full record

SynthesisInternational ophthalmology2020

Analysis from the perspective of cilia: the protective effect of PARP inhibitors on visual function during light-induced damage.

Lin Che, Jing-Yao Song, Yan Lou, Guang-Yu Li

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lin CheDepartment of Ophthalmology, Second Hospital of Jilin University, Changchun, 130041, China.
Jing-Yao SongDepartment of Ophthalmology, Second Hospital of Jilin University, Changchun, 130041, China.
Yan LouDepartment of Nephropathy, Second Hospital of Jilin University, Changchun, 130041, China.
Guang-Yu LiDepartment of Ophthalmology, Second Hospital of Jilin University, Changchun, 130041, China. liguangyu@aliyun.com.
Second Affiliated Hospital of Jilin University · CN

Funding

National Natural Science Foundation of China 81570864Natural Science Foundation of Jilin Province 20160101004JCNatural Science Foundation of Jilin Province 20160414045GHNatural Science Foundation of Jilin Province 2016J041
6 · The paper itself

Abstract

purposeTo analyze the protective effect of PARP inhibitors on light-damaged retina and explore its possible mechanism from the perspective of ciliopathy.

methodsA systematic review of the literature was performed to investigate the protection of PARP inhibition on light-damaged cilia. PubMed database was retrieved to find the relevant studies and 119 literatures were involved in the review.

resultsIn retina, the outer segment of photoreceptor is regarded as a special type of primary cilium, so various retinal diseases actually belong to a type of ciliopathy. The retina is the only central nervous tissue exposed to light, but poly (ADP-ribose) polymerase (PARP), as a nuclear enzyme repairing DNA breaks, is overactivated during the light-induced DNA damage, and is involved in the cell death cascade. Studies show that both ATR and phosphorylated Akt colocalize with cilium and play an important role in regulating ciliary function. PARP may function at ATR or PI3K/Akt signal to exert protective effect on cilia.

conclusionPARP inhibitors may protect the cilia/OS of photoreceptor during light-induced damage, which the possible mechanism may be involved in the activation of ATR and PI3K/Akt signal.

Indexed as

AnimalsCiliaEye BurnsHumansLightPoly(ADP-ribose) Polymerase InhibitorsVisual AcuityPoly(ADP-ribose) Polymerase InhibitorsATRCiliaryLight-induced damagePARPPI3K/Akt

Identifiers

PMID31802371
OpenAlexW2991953453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.